Effectiveness of repeated transcranial magnetic stimulation on sleep quality, emotional disturbance and severity of disorder symptoms in patients with emotional disorders

Not Applicable

Conditions: Behavioral and emotional disorders.
Other behavioral and emotional disorders with onset usually occurring in childhood and adolescence

Registration Number: IRCT20240713062416N1

Lead Sponsor: Islamic Azad University Semnan branch

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: All

Target Recruitment: 60

Inclusion Criteria

Patients must be certified by a psychiatrist or psychologist based on DSM-5 or ICD-10 diagnostic criteria.
The age range of participants should be between 18 and 65 years.
Patients must have moderate to severe symptom severity as assessed using validated instruments such as the Beck Depression Scale (BDI), Hamilton Anxiety Scale (HAM-A), or similar instruments.
Patients must sign informed consent and be willing to participate in all repeated transcranial magnetic stimulation sessions and related assessments.
Patients who are currently receiving medication or psychotherapy should have stable treatment and not have any major changes in their treatment for at least 4 weeks before the start of the study.
Patients must have significant problems in sleep quality and emotional disturbances that affect their quality of life and daily performance.

Exclusion Criteria

Patients diagnosed with other psychiatric disorders such as psychotic disorders, bipolar disorders or substance abuse disorders in the period of 6 months before the start of the study.
Taking medications that may interfere with transcranial magnetic stimulation, such as anticonvulsants or antipsychotics.
Patients with serious physical problems such as cardiovascular disease, renal or hepatic failure, or serious neurological disease that may interfere with the treatment protocol.
Patients with metal implants in the head or neck area (such as implanted hearing aids) that may be stimulated by magnetic fields.
Pregnant or lactating women due to unknown risks to the fetus or infant.
Patients who do not attend or follow instructions for repeated transcranial magnetic stimulation sessions or follow-up assessments.
Patients who decide to withdraw from the study at any stage of the research and do not want to continue.

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sleep quality. Timepoint: Before intervention and after 20 intervention sessions. Method of measurement: Pittsburgh Sleep Quality Questionnaire (PSQI).;Emotional disturbance. Timepoint: Before intervention and after 20 intervention sessions. Method of measurement: Emotional disturbance questionnaire (DASS21).;Severity of disorder symptoms. Timepoint: Before intervention and after 20 intervention sessions. Method of measurement: Clinical General Impression Questionnaire (CGI).

Secondary Outcome Measures